^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
PD-1-KO-T cell injection
i
Other names: PD-1 gene-edited T cell injection, PD-1-KO-T cell injection, PD-1 knockout engineered T cells, PD-1 Knockout T Cells
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chengdu MedGenCell
Drug class:
PD1 inhibitor
Related drugs:
almost4years
PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov)
P1, N=12, Completed, Sichuan University | Active, not recruiting --> Completed
Clinical • Trial completion • PD(L)-1 Biomarker • IO biomarker
|
EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase) • PD-1 (Programmed cell death 1) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10)
|
ALK positive
|
PD-1-KO-T cell injection • cyclophosphamide intravenous
Share via
